CoNextions Medical

CoNextions Medical is a private, commercial-stage medical device company founded in 2016 and headquartered in Minneapolis, Minnesota. The company has developed two novel implant systems designed to revolutionize orthopedic soft tissue repair by offering stronger, faster, and more secure fixation compared to traditional suture techniques. With products cleared by the FDA via the 510(k) pathway and a distribution partnership with Stryker in the United States, CoNextions is positioned in the large and established orthopedic surgery market. Its leadership team includes seasoned executives from Stryker and venture capital, providing strong commercial and strategic expertise.

Implant-based platform for superior soft tissue fixation, replacing or augmenting traditional suture. Features simultaneous engagement of tissue and bone/anchor, using components like stainless steel washers and high-strength suture loops to prevent tear-through and simplify procedures.

CoNextions competes against the entrenched standard of care—manual suture techniques and various suture anchor devices from giants like Arthrex, Smith & Nephew, and Johnson & Johnson. Its competitive edge is based on claimed biomechanical superiority (strength, glide) and procedural efficiency. It also competes with other innovative fixation technologies, such as tape or mesh reinforcements.